India’s Covid-19 vaccines ready for human trials: Things to know about Covaxin and ZyCoV-D
  • 4 years ago
Bharat Biotech International Ltd and Zydus Cadila have got an approval from the Drugs Controller General of India for human clinical trials for their indigenously developed vaccine candidates against Sars-Cov-2, the virus which causes the coronavirus disease.
Recommended